Sajive Aleyas, MD
Pulmonary Disease · Deerfield Beach, FLNPI 1225106016
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (31.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Intuitive Surgical at 32.6% of the total. Reporting peaked in 2021 at $8,351 and has fallen 96.0% since, to $335 in 2025.
Across 248 payments — averaging $104.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- Pulmonx Corporation$8K
- AstraZeneca$2K
- Johnson & Johnson$2K
- Covidien LP$1K
- Veran Medical Technologies, Inc.$1K
- plus $3K from 26 others
What the payments were for
- Consulting fees$7,46329%
- Travel & lodging$8,13431%
- Food & beverage$5,87523%
- Education$4,50917%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 34 | $8,467 |
| Pulmonx Corporation | 13 | $7,755 |
| AstraZeneca | 47 | $2,401 |
| Johnson & Johnson | 15 | $2,098 |
| Covidien LP | 13 | $1,259 |
| Veran Medical Technologies, Inc. | 7 | $1,086 |
| GSK | 42 | $780 |
| Galvanize Therapeutics, Inc | 4 | $402 |
| Boehringer Ingelheim | 9 | $216 |
| Actelion Pharmaceuticals US, Inc. | 8 | $208 |
| Getinge USA Sales, LLC | 3 | $169 |
| Insmed, Inc. | 6 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $110 |
| Circassia Inc. | 6 | $101 |
| United Therapeutics Corporation | 4 | $89 |
| Regeneron Healthcare Solutions, Inc. | 4 | $87 |
| Mylan Specialty L.p. | 3 | $84 |
| Baxter Healthcare | 4 | $81 |
| Sanofi | 3 | $70 |
| Boston Scientific | 3 | $58 |
| Pinnacle Biologics, Inc | 2 | $57 |
| Mallinckrodt Hospital Products Inc. | 2 | $47 |
| Bayer | 2 | $40 |
| Amgen | 2 | $39 |
| Mallinckrodt Enterprises LLC | 1 | $25 |
| Advanced Respiratory, Inc | 1 | $20 |
| Pfizer | 1 | $20 |
| Novartis | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $15 |
| Vapotherm Inc | 1 | $13 |
| ERBE USA Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CHARTIS CATHETER$6,437
- ZEPHYR ENDOBRONCHIAL VALVE$6,437
- ZEPHYR DELIVERY CATHETER$6,437
- PULMONX CHARTIS TABLET CONSOLE$6,437
- Da Vinci Surgical System$4,894
- ION$3,000
- Monarch Platform$1,816
- BREZTRI$1,163
- Pulmonx Endobronchial Valve EBV$1,077
- Spin$1,035
- superDimension$904
- ALIYA SYSTEM$386
- FASENRA$250
How this compares
$25,980 in reported general payments places this provider in the 85th percentile of 953 pulmonary disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 13 | $57 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Deerfield Beach
- Franck RahaghiWeston$1.2M
- Michael OttEglin Afb$909K
- Ali JiwaniOrlando$859K
- Anas HadehWeston$800K
- Jennifer FultonJacksonville$665K
- Ricardo Restrepo-JaramilloTampa$555K
- Mark RumbakTampa$528K
- Jose Soto SotoJacksonville$504K
- Javier Perez FernandezMiami$496K
- Domenick ReinaTampa$469K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.